Transaction · 0001231919-26-000457
COAGHemab Therapeutics Holdings, Inc.
Ra Capital Management, L.P.
RA CAPITAL MANAGEMENT, L.P., DIR, reported an open-market or private purchase at Hemab Therapeutics Holdings, Inc. involving 53407.000000 shares for an estimated $1326095.81. Reported holdings after the transaction were 6314525.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Open-market buySEC transaction code PDIR
- Trade date
- May 06, 2026
- Filing date
- May 06, 2026
How reported position traded is calculated
Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 6,261,118 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
COAG price since this filing
Daily closing prices, with the filing date and available return windowsCOAG · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- Buy Code P
- Identifier
- 0001231919-26-000457 Common Stock
- Transaction date
- May 06, 2026 Filed May 06, 2026, 11:16 PM · 0d delay
- Shares
- 53,407 sh $24.83 per share
- Estimated value
- $1.32M Computed from shares × price
- Holdings after
- 6,314,525 sh Indirect · See footnotes
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Buy Director Buy Large Buy Repeat Buyer 10% Owner Buy
Filing-only score
+54 points
Compact filing score computed from stored Form 4 facts. Version v1.
Strong filing signal
This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.
How this score is calculated
- open_market_purchase+12 points
transaction_code = P
Code P is a discretionary open-market purchase. - director_buy+6 points
is_director = true
Director open-market purchase. - cluster_buy+14 points
cluster-buy signal matched
Multiple insiders bought within the configured window. - repeat_buyer+8 points
repeat-buyer signal matched
Same insider bought again within the configured window. - large_buy_absolute+10 points
large-buy signal with absolute_triggered = true
Open-market purchase exceeds the configured absolute threshold. - timely_filing+4 points
reporting_delay_days = 0
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
No officer title
Officer NoDirector Yes10% YesOther No
Footnotes & amended
- F1
Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initi…
- F2
RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund"), RA Capital Nexus II Fund, L.P. (the "Nexus Fund II") and RA Capital Nexus IV Fu…
- F3
Held directly by the Fund.
- F4
Held directly by Nexus Fund II.
- F5
Held directly by Nexus Fund IV.
- F6
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.00 to $24.9994 inclusive. The Reporting Persons undertake to…
- F7
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.495 to $24.455 inclusive. The Reporting Persons undertake to…
- F8
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.505 to $25.00 inclusive. The Reporting Persons undertake to…
Related transactions
Same SEC filing0 other transactions
Recent company activity
COAG0 recent txs